| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.47 | 0.1 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.072 | 0.1 |